Cyprus vs Serbia: Cause of death, by non-communicable diseases, ages 5-14, female
Cyprus
89.1%
in 2021
Serbia
83.2%
in 2021
Cyprus rank
2nd
Serbia rank
3rd
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Cyprus
- Serbia
How they compare
Cyprus currently reports 89.1% against 83.2% in Serbia, a difference of 5.9%.
That makes Cyprus's figure about 1.1 times Serbia's.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Serbia ahead.
Cyprus ranks 2nd and Serbia ranks 3rd of 184 countries.
Across the 3 decades both report, Cyprus averaged higher in 1 and Serbia in 2.
Head to head by decade
| Decade | Cyprus | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.5% | 51.0% | 13.5% | Serbia |
| 2010s | 59.2% | 70.3% | 11.1% | Serbia |
| 2020s | 87.0% | 77.3% | 9.7% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Cyprus or Serbia?
- Cyprus, at 89.1% against 83.2% in Serbia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Cyprus and Serbia?
- 5.9%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and Serbia rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Cyprus ranks 2nd and Serbia ranks 3rd of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.